인공지능(AI) 강화 복약 순응도 센서 시장 보고서(2026년)
Artificial Intelligence (AI)-Enhanced Medication Adherence Sensor Global Market Report 2026
상품코드 : 1939261
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,777,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,796,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,815,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

인공지능(AI)을 활용한 복약 순응도 센서 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 19억 6,000만 달러에서 2026년에는 23억 4,000만 달러로, CAGR 19.7%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 복약 불이동 문제, 만성질환 증가, 디지털 헬스 도입 확대, 임상시험 모니터링 수요, 웨어러블 센서 기술 혁신에 기인한 것으로 보입니다.

인공지능(AI) 강화형 복약 순응도 센서 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 47억 5,000만 달러에 달하며, CAGR은 19.4%에 달할 전망입니다. 예측 기간의 성장 요인으로는 원격 환자 모니터링 확대, AI 기반 복약 순응도 분석, 가치 기반 의료 모델, 고령 인구 증가, 의약품 시험의 디지털화 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 실시간 복약 모니터링, 만성질환 순응도 지원 툴, 원격 환자 모니터링, 고령자 복약 관리, 임상시험 순응도 추적 등을 꼽을 수 있습니다.

원격 환자 모니터링(RPM)에 대한 수요 증가는 향후 인공지능(AI) 강화형 복약순응도 센서 시장의 성장을 촉진할 것으로 예측됩니다. 원격 환자 모니터링(RPM)은 커넥티드 디지털 기술을 통해 기존 의료 환경 밖에서 환자의 건강 데이터를 수집 및 전송하여 임상의가 실시간으로 환자의 상태를 모니터링하고 관리할 수 있게 해줍니다. RPM의 확대는 디지털 헬스케어 인프라에 대한 투자 증가에 힘입어 커넥티드 모니터링 기술을 환자 치료에 통합하는 것을 가속화하고 있습니다. AI 강화 복약순응도 센서는 복약 상황을 실시간으로 추적하고, 복약 순응도 데이터를 의료진에게 전송합니다. 이를 통해 적시에 개입할 수 있으며, 복약 누락을 줄이고, 임상의가 원격으로 치료 순응도를 모니터링할 수 있습니다. 예를 들어 영국 의회 과학기술국에 따르면 2025년 3월 기준 영국에는 12,825개의 가상 병상이 존재하며, 이는 GP 등록자 10만 명당 20개 병상에 해당합니다. 가동률은 76.2%로 9,767명의 환자를 수용하고 있습니다. 따라서 원격 환자 모니터링에 대한 수요 증가가 인공지능(AI) 강화형 복약순응도 센서 시장의 성장을 촉진하고 있습니다.

인공지능(AI) 강화 복약순응도 센서 시장의 주요 기업은 환자 모니터링의 효율성, 복약 순응도 강화, 의료 서비스 프로바이더와의 원활한 데이터 공유를 위해 스마트 알약병 기반 시스템 등 쉽게 통합할 수 있는 솔루션 개발에 주력하고 있습니다. 통합이 용이한 솔루션 개발에 주력하고 있습니다. 스마트 알약병 기반 시스템은 복약 상태를 실시간으로 추적하고, 복약 순응도 데이터를 기록하고, 적시에 복약할 수 있도록 경고 및 알림을 전송하여 임상의에게 실용적인 정보를 제공합니다. 예를 들어 2024년 6월 미국 디지털 헬스 기업 PatchRx는 기존 케어 관리 플랫폼에 실시간 복약 순응도 데이터를 직접 통합할 수 있는 솔루션 'PatchRx Connect'를 발표했습니다. 이를 통해 임상팀은 업무 흐름과 환자 경험을 방해하지 않고 환자의 약물 복용 행동에 대한 즉각적인 인사이트을 얻을 수 있습니다. 이 시스템에는 약물 사용량을 추적하는 스마트 알약 병뚜껑(PatchCap), Wi-Fi나 모바일 앱에 의존하지 않고 안전하게 데이터를 스트리밍하는 셀룰러 게이트웨이, 의료진이 소프트웨어 내에서 복약 순응도 지표를 확인할 수 있는 Connect API가 포함되어 있습니다. 가 포함되어 있습니다. 이를 통해 적시에 개입하여 치료 결과를 개선하고 비용을 절감할 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Artificial intelligence (AI)-enhanced medication adherence sensors are advanced devices that monitor patients' medication intake in real time using intelligent algorithms. They track adherence patterns, analyze data instantly, and provide actionable insights for timely intervention. These systems improve compliance, reduce missed doses, and enhance overall treatment effectiveness. Their advanced analytics enable proactive management of medication routines, supporting better health outcomes.

The main product types of AI-enhanced medication adherence sensors include wearable sensors, ingestible sensors, smart pill bottles, smart packaging, and others. Wearable sensors are devices worn on the body that monitor medication intake and physiological responses using AI algorithms for precise adherence tracking. The sensor technologies incorporate AI algorithms, Internet of Things (IoT) integration, cloud-based solutions, mobile applications, and others, and are distributed through various online and offline channels. They are applied in areas such as chronic disease management, elderly care, clinical trials, home healthcare, and others, serving end-users including patients, healthcare providers, pharmaceutical companies, and others.

Tariffs have increased the cost of imported sensors, microelectronics, wireless modules, and medical grade packaging used in AI enhanced medication adherence devices, raising manufacturing and device costs. These impacts are most pronounced in ingestible sensors, smart pill bottles, and smart packaging segments, particularly in Asia-Pacific and Europe where component sourcing is highly globalized. Higher costs have affected pricing for healthcare providers and pharmaceutical companies. However, tariffs have also encouraged local electronics assembly and packaging production, supporting regional supply chains and improving long term cost stability.

The artificial intelligence (AI)-enhanced medication adherence sensor market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced medication adherence sensor market statistics, including artificial intelligence (AI)-enhanced medication adherence sensor industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced medication adherence sensor market share, detailed artificial intelligence (AI)-enhanced medication adherence sensor market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced medication adherence sensor industry. This artificial intelligence (AI)-enhanced medication adherence sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (ai)-enhanced medication adherence sensor market size has grown rapidly in recent years. It will grow from $1.96 billion in 2025 to $2.34 billion in 2026 at a compound annual growth rate (CAGR) of 19.7%. The growth in the historic period can be attributed to medication non-adherence issues, chronic disease growth, digital health adoption, clinical trial monitoring needs, wearable sensor innovation.

The artificial intelligence (ai)-enhanced medication adherence sensor market size is expected to see rapid growth in the next few years. It will grow to $4.75 billion in 2030 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to remote patient monitoring growth, ai-driven adherence analytics, value-based care models, elderly population expansion, pharma trial digitization. Major trends in the forecast period include real-time medication monitoring, chronic disease compliance tools, remote patient monitoring, elderly medication management, clinical trial adherence tracking.

The rising demand for remote patient monitoring is expected to drive the growth of the artificial intelligence (AI)-enhanced medication adherence sensor market going forward. Remote patient monitoring (RPM) uses connected digital technologies to collect and transmit patients' health data from outside traditional healthcare settings, enabling clinicians to monitor and manage conditions in real time. The expansion of RPM is being fueled by increased investments in digital health infrastructure, accelerating the integration of connected monitoring technologies into patient care. AI-enhanced medication adherence sensors track medication intake in real time and transmit adherence data to healthcare providers, allowing timely interventions, reducing missed doses, and enabling clinicians to monitor treatment compliance remotely. For instance, in April 2025, according to the Parliamentary Office of Science and Technology, England had 12,825 virtual ward beds in March 2025, equivalent to 20 beds per 100,000 GP-registered individuals, with 76.2% occupancy accommodating 9,767 patients. Therefore, the growing demand for remote patient monitoring is driving the artificial intelligence (AI)-enhanced medication adherence sensor market.

Major companies in the artificial intelligence (AI)-enhanced medication adherence sensor market are focusing on developing easy-to-integrate solutions such as smart pill bottle-based systems to streamline patient monitoring, enhance medication compliance, and facilitate seamless data sharing with healthcare providers. Smart pill bottle-based systems track medication intake in real time, record adherence data, and send alerts and reminders to ensure timely dosing while providing actionable insights to clinicians. For instance, in June 2024, PatchRx, a US-based digital health company, launched PatchRx Connect, an easy-to-integrate solution that embeds real-time medication adherence data directly into existing care management platforms. It enables clinical teams to gain immediate insights into patients' medication-taking behaviors without disrupting workflows or patient experience. The system includes a smart pill bottle cap (PatchCap) that tracks medication use, a cellular gateway that streams data securely without Wi-Fi or mobile app dependency, and a Connect API that allows providers to view adherence metrics within their own software, improving treatment outcomes and reducing costs through timely interventions.

In August 2025, Custom Health, a US-based provider of medication management and connected care services, acquired PatchRx for an undisclosed amount. Through this acquisition, Custom Health gains access to PatchRx's smart pill-bottle cap technology and adherence analytics platform, enhancing its medication tracking and intervention capabilities while expanding remote monitoring of patient adherence. PatchRx is a US-based provider of artificial intelligence (AI)-enhanced medication adherence sensors.

Major companies operating in the artificial intelligence (ai)-enhanced medication adherence sensor market are AiCure Inc., AdhereTech Inc., AARDEX Group Ltd., EtectRx Inc., Proteus Digital Health, Adherium Limited, Wisepill Technologies Proprietary Ltd., SMRxT Inc., Amiko Digital Health Limited, MedMinder Systems Inc., Spencer Health Solutions Inc., iZafe Group AB, Evalan B.V., Mango Health, DoseSmart, CarePredict, Catalia Health, Sentrian, MedAdherence, Pilloxa

North America was the largest region in the artificial intelligence (AI)-enhanced medication adherence sensor market in 2025. The regions covered in the artificial intelligence (AI)-enhanced medication adherence sensor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI)-enhanced medication adherence sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence (AI)-enhanced medication adherence sensor market consists of revenues earned by entities by providing services such as real-time monitoring, adherence analysis, alerts and reminders, data reporting, actionable insights, and integration with digital health platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced medication adherence sensor market also includes sales of smart medication dispensers, connected pill organizers, sensor-embedded patches, Bluetooth-enabled monitoring devices, smart dosage caps, and digital health monitoring kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Enhanced Medication Adherence Sensor Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai)-enhanced medication adherence sensor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced medication adherence sensor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced medication adherence sensor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Characteristics

3. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Supply Chain Analysis

4. Global Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Trends And Strategies

5. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Analysis Of End Use Industries

6. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Total Addressable Market (TAM) Analysis for the Market

9. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Segmentation

10. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Regional And Country Analysis

11. Asia-Pacific Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

12. China Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

13. India Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

14. Japan Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

15. Australia Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

16. Indonesia Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

17. South Korea Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

18. Taiwan Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

19. South East Asia Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

20. Western Europe Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

21. UK Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

22. Germany Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

23. France Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

24. Italy Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

25. Spain Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

26. Eastern Europe Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

27. Russia Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

28. North America Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

29. USA Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

30. Canada Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

31. South America Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

32. Brazil Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

33. Middle East Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

34. Africa Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

35. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Regulatory and Investment Landscape

36. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Competitive Landscape And Company Profiles

37. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Other Major And Innovative Companies

38. Global Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market

40. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기